We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+3.92%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$133B
AUM Growth
+$2.97B
(+2.3%)
Cap. Flow
+$494M
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
28.35%
Holding
293
New
7
Increased
75
Reduced
134
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$635M |
| 2 |
United Airlines
UAL
|
+$620M |
| 3 |
Qualcomm
QCOM
|
+$401M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$302M |
| 5 |
Whirlpool
WHR
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$442M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$411M |
| 3 |
Adobe
ADBE
|
+$359M |
| 4 |
Texas Instruments
TXN
|
+$345M |
| 5 |
AT&T
T
|
+$284M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.69% |
| 2 | Healthcare | 23.27% |
| 3 | Industrials | 16.23% |
| 4 | Consumer Discretionary | 9.05% |
| 5 | Financials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
HP
HPQ
$26.5B
| $1.37B | 1.03% |
62,574,549
-530,765
| -0.8% | -$12M |
|
27
KLA
KLAC
$258B
| $1.35B | 1.02% |
124,131,560
-1,173,000
| -0.9% | -$13.1M |
|
28
Alkermes
ALKS
$8.17B
| $1.35B | 1.01% |
23,292,333
+1,419,402
| +6% | +$83M |
|
29
Carnival Corporation Ltd
CCL
$39.1B
| $1.33B | 1% |
20,230,137
-280,072
| -1% | -$19M |
|
|
MON
30
DELISTED
Monsanto Co
MON
| $1.26B | 0.95% |
10,826,092
-92,287
| -0.8% | -$11.1M |
|
31
Intel
INTC
$504B
| $1.26B | 0.94% |
24,115,922
+4,352,762
| +22% | +$207M |
|
32
Boston Scientific
BSX
$72B
| $1.22B | 0.92% |
44,720,041
+842,479
| +2% | +$22.9M |
|
|
33
Qualcomm
QCOM
$173B
| $1.2B | 0.9% |
21,609,105
+6,294,553
| +41% | +$401M |
|
34
Royal Caribbean
RCL
$85.9B
| $1.12B | 0.84% |
9,489,711
-395,285
| -4% | -$49.9M |
|
|
35
BioMarin Pharmaceuticals
BMRN
$12.3B
| $1.12B | 0.84% |
13,766,539
+3,521,244
| +34% | +$302M |
|
36
Cisco
CSCO
$476B
| $1.11B | 0.84% |
25,949,486
-597,121
| -2% | -$25.3M |
|
|
ABMD
37
DELISTED
Abiomed Inc
ABMD
| $1.11B | 0.83% |
3,822,690
-256,700
| -6% | -$65.1M |
|
38
Thermo Fisher Scientific
TMO
$216B
| $1.05B | 0.79% |
5,107,184
-37,060
| -0.7% | -$7.78M |
|
|
39
Bristol-Myers Squibb
BMY
$131B
| $1.04B | 0.78% |
16,430,950
+9,873,372
| +151% | +$635M |
|
40
Ross Stores
ROST
$81.3B
| $1.01B | 0.76% |
12,910,949
-371,198
| -3% | -$29.5M |
|
41
Wells Fargo
WFC
$262B
| $993M | 0.75% |
18,946,292
+540,627
| +3% | +$32.1M |
|
42
TJX Companies
TJX
$178B
| $894M | 0.67% |
21,914,648
-1,277,600
| -6% | -$50.5M |
|
43
Intuit
INTU
$91.2B
| $890M | 0.67% |
5,134,191
-239,334
| -4% | -$40.3M |
|
44
Flex
FLEX
$45.1B
| $870M | 0.65% |
70,721,138
+1,049,277
| +2% | +$14.3M |
|
45
Abbott
ABT
$185B
| $868M | 0.65% |
14,480,510
-133,009
| -0.9% | -$8.01M |
|
|
DFS
46
DELISTED
Discover Financial Services
DFS
| $852M | 0.64% |
11,839,642
+707,617
| +6% | +$54.6M |
|
47
BlackBerry
BB
$5.25B
| $841M | 0.63% |
73,143,672
-614,873
| -0.8% | -$7.82M |
|
48
CarMax
KMX
$8.34B
| $814M | 0.61% |
13,149,023
-900,552
| -6% | -$58.9M |
|
49
Deere & Co
DE
$168B
| $813M | 0.61% |
5,231,921
-254,038
| -5% | -$41.2M |
|
|
MRSH
50
Marsh
MRSH
$91.5B
| $808M | 0.61% |
9,779,786
-96,359
| -1% | -$7.98M |
|
Similar funds
VAM
Primecap Management's Q1 2018 Portfolio in Review
As of Q1 2018, Primecap Management held 293 positions worth $133B, up 2.3% from $130B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 4.8%. Primecap Management opened 7 new positions and exited 7, leaving the 293-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2018 buy was Moody's: 181,000 shares worth $29.2M.
- Primecap Management added most to Bristol-Myers Squibb in Q1 2018, an estimated $635M increase.
- Primecap Management's biggest Q1 2018 reduction was NVIDIA, cutting an estimated $442M.
- Primecap Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $411M.
- Primecap Management's ten largest holdings make up 28% of its $133B portfolio in Q1 2018.
- Primecap Management opened 7 new positions and closed 7 in Q1 2018.
- Primecap Management's portfolio value rose 2.3% quarter-over-quarter to $133B.
Based on Primecap Management's 13F filing for Q1 2018, filed 14 May 2018.